Teladoc Health Inc (TDOC)
9.05
-0.16
(-1.74%)
USD |
NYSE |
Nov 18, 16:00
9.01
-0.04
(-0.44%)
Pre-Market: 07:42
Teladoc Health Revenue (Quarterly): 640.51M for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 640.51M |
| June 30, 2024 | 642.44M |
| March 31, 2024 | 646.13M |
| December 31, 2023 | 660.53M |
| September 30, 2023 | 660.24M |
| June 30, 2023 | 652.41M |
| March 31, 2023 | 629.24M |
| December 31, 2022 | 637.71M |
| September 30, 2022 | 611.40M |
| June 30, 2022 | 592.38M |
| March 31, 2022 | 565.35M |
| December 31, 2021 | 554.24M |
| September 30, 2021 | 521.66M |
| June 30, 2021 | 503.14M |
| March 31, 2021 | 453.68M |
| December 31, 2020 | 383.32M |
| September 30, 2020 | 288.81M |
| June 30, 2020 | 241.03M |
| March 31, 2020 | 180.80M |
| December 31, 2019 | 156.49M |
| September 30, 2019 | 137.97M |
| June 30, 2019 | 130.28M |
| Date | Value |
|---|---|
| March 31, 2019 | 128.57M |
| December 31, 2018 | 122.74M |
| September 30, 2018 | 110.96M |
| June 30, 2018 | 94.56M |
| March 31, 2018 | 89.64M |
| December 31, 2017 | 77.14M |
| September 30, 2017 | 68.65M |
| June 30, 2017 | 44.59M |
| March 31, 2017 | 42.90M |
| December 31, 2016 | 37.40M |
| September 30, 2016 | 32.38M |
| June 30, 2016 | 26.49M |
| March 31, 2016 | 26.89M |
| December 31, 2015 | 22.64M |
| September 30, 2015 | 19.97M |
| June 30, 2015 | 18.28M |
| March 31, 2015 | 16.49M |
| December 31, 2014 | 12.93M |
| September 30, 2014 | 10.90M |
| June 30, 2014 | 10.29M |
| March 31, 2014 | 9.407M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
156.49M
Minimum
Dec 2019
660.53M
Maximum
Dec 2023
511.07M
Average
578.86M
Median
Revenue (Quarterly) Benchmarks
| American Shared Hospital Services | 6.999M |
| Astrana Health Inc | 478.71M |
| Cryo-Cell International Inc | 8.067M |
| P3 Health Partners Inc | 362.12M |
| Biote Corp | 51.38M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -33.28M |
| Total Expenses (Quarterly) | 680.87M |
| EPS Diluted (Quarterly) | -0.19 |
| Enterprise Value | 1.856B |
| Gross Profit Margin (Quarterly) | 71.94% |
| Profit Margin (Quarterly) | -5.20% |
| Earnings Yield | -63.76% |
| Normalized Earnings Yield | -22.15 |